Immunosuppressive properties of cyclophosphamide analogues.
D000707:Anaphylaxis / Q000517:prevention & control; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000921:Antibody-Producing Cells / Q000187:drug effects; D003498:Cyclic P-Oxides / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004912:Erythrocytes / Q000276:immunology; D005021:Ethylamines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006386:Hemagglutination Tests; D007110:Immunity, Active / Q000187:drug effects; D007111:Immunity, Cellular / Q000187:drug effects; D007074:Immunoglobulin G / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008623:Mercaptoethanol / Q000494:pharmacology; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D010078:Oxazines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010567:Pertussis Vaccine; D051381:Rats; D012756:Sheep; D014436:Typhoid-Paratyphoid Vaccines
D003498:Cyclic P-Oxides; D005021:Ethylamines; D007074:Immunoglobulin G; D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D009588:Nitrogen Mustard Compounds; D010078:Oxazines; D010567:Pertussis Vaccine; D014436:Typhoid-Paratyphoid Vaccines; D008623:Mercaptoethanol; D003520:Cyclophosphamide